STRS Ohio’s Aerie Pharmaceuticals AERI Stock Holding History

STRS Ohio’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-200	Closed	-$12.9K	–	2202
2018 Q2	$13K	Buy	+200	New	+$11.2K	﹤0.01%	2079
2014 Q2	–	Sell	-1,500	Closed	-$32K	–	1783
2014 Q1	$32K	Sell	1,500 -1,600	-52%	-$32.3K	﹤0.01%	1652
2013 Q4	$56K	Buy	+3,100	New	+$40.4K	﹤0.01%	1628

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

STRS Ohio's AERI Position: Q3 2018 in Review

STRS Ohio sold out of Aerie Pharmaceuticals (AERI) in Q3 2018, closing a stake of 200 shares — an estimated $12.9K sold.

STRS Ohio first reported a position in AERI in Q4 2013 and held it in 3 quarters. The position peaked at $56K in Q4 2013. 176 funds tracked by Wall St. Rank hold AERI as of Q3 2018.

STRS Ohio reported no remaining Aerie Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
STRS Ohio sold 200 Aerie Pharmaceuticals shares in Q3 2018, an estimated $12.9K.
STRS Ohio first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 3 quarters.
STRS Ohio's Aerie Pharmaceuticals position peaked at $56K in Q4 2013.
176 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2018.

Based on STRS Ohio's 13F filing for Q3 2018, filed 19 Oct 2018.